Drug Development, Drug Pricing and White Paper

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Drug Development

Drug Pricing

White Paper

The Brazilian pharma market: Key information and what may change

Pharmaceutical Technology

DECEMBER 9, 2022

There are also strict price controls, which in some cases can limit profitability for manufacturers. Brazilian public spending on healthcare, drug pricing reforms and remote medicine. These treatments may still be in development or already have approval somewhere in the world. </p>

Drug Pricing

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars

NHC Comments on IRA Guidance Response

Putting Patients First Blog

APRIL 14, 2023

Driven by the work of the Food and Drug Administration on patient-focused drug development (PFDD), many companies in the biopharmaceutical community have devoted significant resources to better understand patient populations and are working to bring to market products that best suit their needs. Sincerely, Randall L.

Drug Pricing

Drug Pricing Drug Development Documentation Communication

Pharmacist Digest

The Brazilian pharma market: Key information and what may change

NHC Comments on IRA Guidance Response

Stay Connected